148 related articles for article (PubMed ID: 33642141)
61. An interactive Bayesian model for prediction of lymph node ratio and survival in pancreatic cancer patients.
Smith BJ; Mezhir JJ
J Am Med Inform Assoc; 2014 Oct; 21(e2):e203-11. PubMed ID: 24444460
[TBL] [Abstract][Full Text] [Related]
62. Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival.
Morales-Oyarvide V; Rubinson DA; Dunne RF; Kozak MM; Bui JL; Yuan C; Qian ZR; Babic A; Da Silva A; Nowak JA; Khalaf N; Brais LK; Welch MW; Zellers CL; Ng K; Chang DT; Miksad RA; Bullock AJ; Tseng JF; Swanson RS; Clancy TE; Linehan DC; Findeis-Hosey JJ; Doyle LA; Hornick JL; Ogino S; Fuchs CS; Hezel AF; Koong AC; Wolpin BM
Br J Cancer; 2017 Dec; 117(12):1874-1882. PubMed ID: 28982112
[TBL] [Abstract][Full Text] [Related]
63. The Eighth Edition of the American Joint Committee on Cancer Distant Metastases Stage Classification for Metastatic Pancreatic Neuroendocrine Tumors Might Be Feasible for Metastatic Pancreatic Ductal Adenocarcinomas.
Wen J; Chen J; Liu D; Xu X; Fan M; Zhang Z
Neuroendocrinology; 2020; 110(5):364-376. PubMed ID: 31357196
[TBL] [Abstract][Full Text] [Related]
64. Assessment of the American Joint Commission on Cancer 8th Edition Staging System for Patients with Pancreatic Neuroendocrine Tumors: A Surveillance, Epidemiology, and End Results analysis.
Li X; Gou S; Liu Z; Ye Z; Wang C
Cancer Med; 2018 Mar; 7(3):626-634. PubMed ID: 29380547
[TBL] [Abstract][Full Text] [Related]
65. Impact of tumor grade on pancreatic cancer prognosis: validation of a novel TNMG staging system.
Rochefort MM; Ankeny JS; Kadera BE; Donald GW; Isacoff W; Wainberg ZA; Hines OJ; Donahue TR; Reber HA; Tomlinson JS
Ann Surg Oncol; 2013 Dec; 20(13):4322-9. PubMed ID: 23943022
[TBL] [Abstract][Full Text] [Related]
66. Lymph node ratio versus number of affected lymph nodes as predictors of survival for resected pancreatic adenocarcinoma.
Bhatti I; Peacock O; Awan AK; Semeraro D; Larvin M; Hall RI
World J Surg; 2010 Apr; 34(4):768-75. PubMed ID: 20052471
[TBL] [Abstract][Full Text] [Related]
67. Lymph node examination and survival in resected pancreatic ductal adenocarcinoma: retrospective study.
Goess R; Jäger C; Perinel J; Pergolini I; Demir E; Safak O; Scheufele F; Schorn S; Muckenhuber A; Adham M; Novotny A; Ceyhan GO; Friess H; Demir IE
BJS Open; 2024 Jan; 8(1):. PubMed ID: 38271272
[TBL] [Abstract][Full Text] [Related]
68. Challenging a dogma; AJCC 8th staging system is not sufficient to predict outcomes of patients with malignant pleural mesothelioma.
Abdel-Rahman O
Lung Cancer; 2017 Nov; 113():128-133. PubMed ID: 29110839
[TBL] [Abstract][Full Text] [Related]
69. Integrated ratio of metastatic to examined lymph nodes and number of metastatic lymph nodes into the AJCC staging system for colon cancer.
Gao P; Song YX; Wang ZN; Xu YY; Tong LL; Zhu JL; Tang QC; Xu HM
PLoS One; 2012; 7(4):e35021. PubMed ID: 22529970
[TBL] [Abstract][Full Text] [Related]
70. Equipping the American Joint Committee on Cancer Staging for Resectable Pancreatic Ductal Adenocarcinoma with Tumor Grade: A Novel Staging System.
Ren H; Wu CR; Qiu GT; Zhang LP; Aimaiti S; Wang CF
J Oncol; 2020; 2020():9093729. PubMed ID: 33014058
[TBL] [Abstract][Full Text] [Related]
71. Metastatic lymph node ratio successfully predicts prognosis in western gastric cancer patients.
Kutlu OC; Watchell M; Dissanaike S
Surg Oncol; 2015 Jun; 24(2):84-8. PubMed ID: 25912951
[TBL] [Abstract][Full Text] [Related]
72. Impact of examined lymph node count on staging and long-term survival of patients with node-negative stage III gastric cancer: a retrospective study using a Chinese multi-institutional registry with Surveillance, Epidemiology, and End Results (SEER) data validation.
Zhang N; Bai H; Deng J; Wang W; Sun Z; Wang Z; Xu H; Zhou Z; Liang H
Ann Transl Med; 2020 Sep; 8(17):1075. PubMed ID: 33145294
[TBL] [Abstract][Full Text] [Related]
73. The diversity between curatively resected pancreatic head and body-tail cancers based on the 8th edition of AJCC staging system: a multicenter cohort study.
Sheng W; Dong M; Wang G; Shi X; Gao W; Wang K; Song H; Shi G; Tan X
BMC Cancer; 2019 Oct; 19(1):981. PubMed ID: 31640615
[TBL] [Abstract][Full Text] [Related]
74. Revolutionizing T3-4N0-2M0 gastric cancer staging with an innovative pathologic N classification system.
Yin K; Jin X; Pan Y; Zi M; Zheng Y; Ma Y; Pang C; Liu K; Chen J; Wei Y; Liu D; Cheng X; Yuan L
J Gastrointest Surg; 2024 May; ():. PubMed ID: 38821213
[TBL] [Abstract][Full Text] [Related]
75. Validation of the prognostic value of new sub-stages within the AJCC 8th edition of non-small cell lung cancer.
Abdel-Rahman O
Clin Transl Oncol; 2017 Nov; 19(11):1414-1420. PubMed ID: 28497423
[TBL] [Abstract][Full Text] [Related]
76. Accurate Nodal Staging in Pancreatic Cancer in the Era of Neoadjuvant Therapy.
Javed AA; Ding D; Baig E; Wright MJ; Teinor JA; Mansoor D; Thompson E; Hruban RH; Narang A; Burns WR; Burkhart RA; Lafaro K; Weiss MJ; Cameron JL; Wolfgang CL; He J
World J Surg; 2022 Mar; 46(3):667-677. PubMed ID: 34994834
[TBL] [Abstract][Full Text] [Related]
77. Toward an Optimized Staging System for Pancreatic Ductal Adenocarcinoma: A Clinically Interpretable, Artificial Intelligence-Based Model.
Bertsimas D; Margonis GA; Huang Y; Andreatos N; Wiberg H; Ma Y; Mcintyre C; Pulvirenti A; Wagner D; van Dam JL; Gavazzi F; Buettner S; Imai K; Stasinos G; He J; Kamphues C; Beyer K; Seeliger H; Weiss MJ; Kreis M; Cameron JL; Wei AC; Kornprat P; Baba H; Koerkamp BG; Zerbi A; D'Angelica M; Wolfgang CL
JCO Clin Cancer Inform; 2021 Dec; 5():1220-1231. PubMed ID: 34936469
[TBL] [Abstract][Full Text] [Related]
78. A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma.
Zhu L; Shen S; Wang H; Zhang G; Yin X; Shi X; Gao S; Han J; Ren Y; Wang J; Jiang H; Guo S; Jin G
BMC Cancer; 2023 Aug; 23(1):790. PubMed ID: 37612635
[TBL] [Abstract][Full Text] [Related]
79. Development and Validation of a New Lymph Node Ratio-Based Staging System for Ampullary Carcinoma After Curative Pancreaticoduodenectomy.
Zhang X; Sun C; Li Z; Wang T; Zhao L; Niu P; Guo C; Chen Y; Che X; Zhao D
Front Oncol; 2021; 11():811595. PubMed ID: 35127524
[TBL] [Abstract][Full Text] [Related]
80. Real-world implications of nonbiological factors with staging, clinical management, and prognostic prediction in pancreatic ductal adenocarcinoma.
Wang C; Chen H; Deng X; Xu W; Shen B
Cancer Med; 2023 Jan; 12(1):651-662. PubMed ID: 35661437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
